Andrew Diamos
9Patents
1h-index
7Co-inventors
40Inventor score
Filing activity: Jan 22, 2014 → Nov 8, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10125373B2 | Geminiviral vector for expression of rituximab | Chemistry; Metallurgy | 17 | Active |
| US11857613B2 | Vaccine for prevention of necrotic enteritis in poultry | Chemistry; Metallurgy | 0 | Active |
| US11564981B2 | Vaccine for prevention of necrotic enteritis in poultry | Chemistry; Metallurgy | 0 | Active |
| US12297443B2 | Optimized plant expression systems | Chemistry; Metallurgy | 0 | Active |
| US11058766B2 | Universal vaccine platform | Emerging Cross-Sectional Technologies | 0 | Active |
| US12286636B2 | Replicating and non-replicating vectors for recombinant protein production in plants and method of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11865174B2 | Universal vaccine platform | Emerging Cross-Sectional Technologies | 0 | Active |
| US11154606B2 | Vaccine for prevention of necrotic enteritis in poultry | Chemistry; Metallurgy | 0 | Active |
| US12257302B2 | Universal vaccine platform | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.